John Alexander Kelly Precision Biosciences Inc (DTIL) insider trading activity

John Alexander Kelly is Chief Financial Officer of PRECISION BIOSCIENCES INC. Currently has a direct ownership of 38,073 shares of DTIL, which is worth approximately $171,328. The most recent transaction as insider was on Nov 21, 2024, when has been sold 3,000 shares (Common Stock) at a price of $6.76 per share, resulting in proceeds of $20,280. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 38.1K

20.99% 3M change

92.35% 12M change

Total Value Held $171,328

John Alexander Kelly Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 21 2024	BUY Open market or private purchase	$20,280 $6.76 p/Share	3,000 Added 7.3%	38,073 Common Stock
Nov 02 2024	BUY Exercise of conversion of derivative security	-	3,605 Added 9.32%	35,073 Common Stock
Jun 07 2024	BUY Exercise of conversion of derivative security	-	454 Added 1.42%	31,468 Common Stock
May 08 2024	BUY Grant, award, or other acquisition	$100,008 $12.0 p/Share	8,334 Added 21.18%	31,014 Common Stock
May 01 2024	BUY Exercise of conversion of derivative security	-	1,702 Added 6.98%	22,680 Common Stock
Feb 29 2024	BUY Grant, award, or other acquisition	$9,361 $18.5 p/Share	506 Added 2.36%	20,978 Common Stock
Jan 20 2024	BUY Exercise of conversion of derivative security	-	116,690 Added 15.97%	614,169 Common Stock
Nov 02 2023	BUY Exercise of conversion of derivative security	-	108,188 Added 17.86%	497,479 Common Stock
Aug 31 2023	BUY Grant, award, or other acquisition	$2,320 $0.39 p/Share	5,951 Added 1.51%	389,291 Common Stock
Aug 18 2023	BUY Grant, award, or other acquisition	$43,200 $0.48 p/Share	90,000 Added 19.01%	383,340 Common Stock
Jun 07 2023	BUY Exercise of conversion of derivative security	-	47,726 Added 13.99%	293,340 Common Stock
Mar 17 2023	BUY Open market or private purchase	$17,200 $0.86 p/Share	20,000 Added 7.53%	245,614 Common Stock
Mar 03 2023	BUY Exercise of conversion of derivative security	-	51,071 Added 18.46%	225,614 Common Stock
Feb 28 2023	BUY Grant, award, or other acquisition	$11,024 $0.95 p/Share	11,605 Added 6.23%	174,543 Common Stock
Sep 23 2022	BUY Open market or private purchase	$10,086 $1.23 p/Share	8,200 Added 4.79%	162,938 Common Stock
Sep 22 2022	BUY Open market or private purchase	$49,630 $1.34 p/Share	37,037 Added 19.31%	154,738 Common Stock
Jun 22 2022	BUY Open market or private purchase	$50,676 $1.5 p/Share	33,784 Added 22.3%	117,701 Common Stock
Jun 07 2022	BUY Exercise of conversion of derivative security	-	47,728 Added 36.26%	83,917 Common Stock
Mar 17 2022	BUY Open market or private purchase	$51,365 $3.08 p/Share	16,677 Added 31.55%	36,189 Common Stock
Feb 28 2022	BUY Grant, award, or other acquisition	$9,798 $3.61 p/Share	2,714 Added 12.21%	19,512 Common Stock
Aug 31 2021	BUY Grant, award, or other acquisition	$10,659 $10.68 p/Share	998 Added 5.61%	16,798 Common Stock

JAK

John Alexander Kelly

Chief Financial Officer

Durham, NC

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DTIL shares.

Notify only if

Value

Insider Trading

Get notified when an Precision Biosciences Inc insider buys or sells DTIL shares.

Notify only if

Operation

Value

Type

News

Receive news related to PRECISION BIOSCIENCES INC

Track Activities on DTIL

Account